Some 2-(4-bromophenoxymethyl)-6-iodo-3-substituted quinazolin-4(3H)ones: Synthesis, cytotoxic activity, EGFR inhibition and molecular docking

被引：2

作者：

Abbas, Safinaz E-S. ^{[1
]}

Abdel-Gawad, Nagwa M. ^{[1
]}

George, Riham F. ^{[1
]}

Abu Elyazid, Mohamed G. ^{[1
]}

Zaater, Marwa A. ^{[1
]}

El-Ashrey, Mohamed K. ^{[1
,2
]}

机构：

[1] Cairo Univ, Dept Pharmaceut Chem, Fac Pharm, Cairo 11562, Egypt

[2] King Salman Int Univ, Fac Pharm, Dept Med Chem, Ras Sedr, South Sinai, Egypt

来源：

JOURNAL OF MOLECULAR STRUCTURE | 2022年 / 1269卷

关键词：

Quinazoline; EGFR; HCT116; MCF-7; A-549; Molecular docking; Molecular dynamics simulation; EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR; BREAST-CANCER; CELL-DEATH; EXPRESSION; ADENOCARCINOMA; MUTATIONS;

D O I：

10.1016/j.molstruc.2022.133851

中图分类号：

O64 [物理化学（理论化学）、化学物理学];

学科分类号：

070304 ; 081704 ;

摘要：

Different 6-iodo-2-(4-bromophenyoxymethyl)-3-substituted quinazolin-4-ones were prepared and tested for their cytotoxic activity against MCF-7 (breast), A-549 (lung) and HCT-116 (colon) cancer cell lines as well as normal fibroblasts WI-38. They revealed promising activity specially against A-549 and HCT 116 compared to Erlotinib. Compounds eliciting high cytotoxicity were further tested for their EGFR inhibitory activity and it was found that compounds 8, 9, 11a, b revealed superior activity than Gefitinib. Molecular docking of these compounds at the active site of EGFR confirmed the obtained activity as they showed binding interactions with the key amino acids as that of co-crystallized ligand. Therefore, these compounds can be considered as a promising core for anticancer agents with EGFR inhibitory activity. (C) 2022 Elsevier B.V. All rights reserved.

引用

页数：13

共 50 条

[1] Synthesis and Biological Activity of Some New Substituted Quinazolin-4(3H)-Ones
Dawood, Nadia T. A.
Abdel-Ghaffar, Nahed F.
Soliman, Fekria M. A.
EGYPTIAN JOURNAL OF CHEMISTRY, 2011, 54 (01): : 1 - 15
[2] Synthesis, antiviral and cytotoxic investigation of 2-phenyl-3-substituted quinazolin-4(3H)-ones
Krishnan, S. K.
Ganguly, S.
Veerasamy, R.
Jan, B.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2011, 15 (06) : 673 - 681
[3] A NOVEL SYNTHESIS OF 2-SUBSTITUTED QUINAZOLIN-4(3H)-ONES
SVETLIK, J
HETEROCYCLES, 1981, 16 (08) : 1281 - 1285
[4] SYNTHESIS OF ISOXAZOLYL QUINAZOLIN-4 (3H)-ONES
Rajanarendar, E.
Venkateshwarlu, P.
Ramakrishna, S.
INDIAN JOURNAL OF HETEROCYCLIC CHEMISTRY, 2012, 22 (02) : 95 - 98
[5] Ecofriendly synthesis of quinazolin-4(3H)-ones
Kidwai, M
Rastogi, R
Rastogi, S
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 2004, 43 (02): : 423 - 425
[6] Synthesis of quinazolin-4(3H)-ones, an update
Picos-Corrales, Lorenzo A.
Sarmiento-Sanchez, Juan I.
CHEMISTRY OF HETEROCYCLIC COMPOUNDS, 2018, 54 (08) : 762 - 764
[7] SYNTHESIS OF 2-SUBSTITUTED BENZO[G]QUINAZOLIN-4(3H)-ONES
KUMAR, PR
REDDY, MS
INDIAN JOURNAL OF CHEMISTRY SECTION B-ORGANIC CHEMISTRY INCLUDING MEDICINAL CHEMISTRY, 1994, 33 (09): : 883 - 884
[8] Convenient synthesis of 2,3-disubstituted quinazolin-4(3H)-ones and 2-styryl-3-substituted quinazolin-4(3H)-ones: applications towards the synthesis of drugs
Kumar, Dinesh
Jadhavar, Pradeep S.
Nautiyal, Manesh
Sharma, Himanshu
Meena, Prahlad K.
Adane, Legesse
Pancholia, Sahaj
Chakraborti, Asit K.
RSC ADVANCES, 2015, 5 (39) : 30819 - 30825
[9] Synthesis and biofilm inhibition studies of 2-(2-amino-6-arylpyrimidin-4-yl) quinazolin-4(3H)-ones
Rasapalli, Sivappa
Murphy, Zachary F.
Sammeta, Vamshikrishna Reddy
Golen, James A.
Weig, Alexander W.
Melander, Roberta J.
Melander, Christian
Macha, Prathyushakrishna
Vasudev, Milana C.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2020, 30 (23)
[10] Synthesis and Evaluation of Antioxidant Properties of 2-Substituted Quinazolin-4(3H)-ones
Mravljak, Janez
Slavec, Lara
Hrast, Martina
Sova, Matej
MOLECULES, 2021, 26 (21):

← 1 2 3 4 5 →